New mRNA-Based Heart Failure Therapy

Biotechnology and medical science researchers

Moderna Inc. has announced that their new mRNA-based heart failure therapy has begun Phase 1 clinical trials.

In a major breakthrough for medical science, Moderna Inc. has announced that their new mRNA-based heart failure therapy has begun Phase 1 clinical trials. This …

Show More »